Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184–7.

Article  PubMed  PubMed Central  Google Scholar 

Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012;48:1624–32.

Article  PubMed  Google Scholar 

Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Miyazaki T, et al. Comprehensive registry of esophageal cancer in Japan, 2015. Esophagus. 2023;20:1–28.

Article  PubMed  Google Scholar 

Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20:69–83.

Article  CAS  PubMed  Google Scholar 

Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662–5.

Article  PubMed  Google Scholar 

Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–9.

Article  CAS  PubMed  Google Scholar 

Liu K, Zhang W, Chen X, Chen X, Yang K, Zhang B, et al. Comparison on clinicopathological features and prognosis between esophagogastric junctional adenocarcinoma (Siewert II/III types) and distal gastric adenocarcinoma: retrospective cohort study, a single institution, high volume experience in China. Medicine (Baltimore). 2015;94:e1386.

Article  PubMed  Google Scholar 

Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.

Article  Google Scholar 

Suh YS, Na D, Lee JS, Chae J, Kim E, Jang G, et al. Comprehensive molecular characterization of adenocarcinoma of the gastroesophageal junction between esophageal and gastric adenocarcinomas. Ann Surg. 2022;275:706–17.

Article  PubMed  Google Scholar 

Nunobe S, Nakanishi Y, Taniguchi H, Sasako M, Sano T, Kato H, et al. Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int. 2007;57:315–21.

Article  CAS  PubMed  Google Scholar 

Yamaguchi K, Urakami K, Ohshima K, Mochizuki T, Akiyama Y, Uesaka K, et al. Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—. Biomed Res. 2014;35:407–12.

Article  CAS  PubMed  Google Scholar 

Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, et al. Japanese version of the cancer genome atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients. Cancer Sci. 2020;111:687–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.

Furukawa K, Hatakeyama K, Terashima M, Nagashima T, Urakami K, Ohshima K, et al. Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE. Gastric Cancer. 2022;25:138–48.

Article  CAS  PubMed  Google Scholar 

Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.

Article  Google Scholar 

Ichikawa H, Nagahashi M, Shimada Y, Hanyu T, Ishikawa T, Kameyama H, et al. Actionable gene-based classification toward precision medicine in gastric cancer. Genome Med. 2017;9:93.

Article  PubMed  PubMed Central  Google Scholar 

Ajani JA IH, Sano T, et al. Stomach. In: MB A, editor. AJCC Cancer Staging Manual. 8th ed. New York: Springer-Verlag; 2016. p. 203–20.

Japanese Gastric Cancer Treatment Guidelines. 6th edition. Gastric Cancer. 2021;2023(26):1–25.

Google Scholar 

Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-γ-related mrna profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127:2930–40.

Article  PubMed  PubMed Central  Google Scholar 

Krishnamurthy HK, Rajavelu I, Pereira M, Jayaraman V, Krishna K, Wang T, et al. Inside the genome: understanding genetic influences on oxidative stress. Front Genet. 2024;15:1397352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol. 2015;26:259–71.

Article  CAS  PubMed  Google Scholar 

Geng Q, Lao J, Zuo X, Chen S, Bei JX, Xu D. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes. J Pathol. 2020;252:263–73.

Article  CAS  PubMed  Google Scholar 

Echizen K, Horiuchi K, Aoki Y, Yamada Y, Minamoto T, Oshima H, et al. NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene. 2019;38:4250–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joo JH, Oh H, Kim M, An EJ, Kim R-K, Lee S-Y, et al. NADPH oxidase 1 activity and ROS generation are regulated by Grb2/Cbl-mediated proteasomal degradation of NoxO1 in colon cancer cells. Cancer Res. 2016;76:855–65.

Article  CAS  PubMed  Google Scholar 

Pecchillo Cimmino T, Ammendola R, Cattaneo F, Esposito G. NOX dependent ROS generation and cell metabolism. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24032086.

Article  PubMed  PubMed Central  Google Scholar 

Wang HP, Wang X, Gong LF, Chen WJ, Hao Z, Feng SW, et al. Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway. Eur Rev Med Pharmacol Sci. 2016;20:4474–81.

PubMed  Google Scholar 

Jung SH, Kim SM, Lee CE. Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation. Oncotarget. 2016;7:62559–71.

Article  PubMed  PubMed Central  Google Scholar 

Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, et al. ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell. 2013;12:761–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zulpa A, Muttiah B, Vellasamy K, Mariappan V, Vadivelu J. Dentatin triggers ROS-mediated apoptosis, G0/G1 cell cycle arrest and release of Th1-related cytokines in colorectal carcinoma cells. J Taibah Univ Sci. 2023. https://doi.org/10.1080/16583655.2023.2194231.

Article  Google Scholar 

Nakayama H, Kitayama J, Muto T, Nagawa H. Characterization of intracellular cytokine profile of CD4(+) T cells in peripheral blood and tumor-draining lymph nodes of patients with gastrointestinal cancer. Jpn J Clin Oncol. 2000;30:301–5.

Article  CAS  PubMed  Google Scholar 

Chen H, Jiang T, Lin F, Guan H, Zheng J, Liu Q, et al. PD-1 inhibitor combined with apatinib modulate the tumor microenvironment and potentiate anti-tumor effect in mice bearing gastric cancer. Int Immunopharmacol. 2021;99:107929.

Article  CAS  PubMed  Google Scholar 

Bergamaschi C, Pandit H, Nagy BA, Stellas D, Jensen SM, Bear J, et al. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10. J Immunother Cancer. 2020;8:e000599.

Article  PubMed  PubMed Central  Google Scholar 

Murphy WJ, Welniak L, Back T, Hixon J, Subleski J, Seki N, et al. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses 1. J Immunol. 2003;170:2727–33.

Article  CAS  PubMed  Google Scholar 

Kim YJ, Lim J, Kang JS, Kim HM, Lee HK, Ryu HS, et al. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. A